Leaflet METASTRON 37 MBq / ml solution for injection


Indicated for: bone pain associated with metastases

Route of administration: injectable

Substance: strontium chloride (analgesic and antipyretic)

ATC: V10BX01 (Various | Pain palliation (bone seeking agents) | Various pain palliation radiopharmaceuticals)

Strontium chloride is a chemical compound used in nuclear medicine for the diagnosis of certain bone conditions. It is used as a radioactive contrast agent, allowing the visualization of bone structures during imaging scans.

The medication is administered intravenously, as directed by a doctor, prior to the scan. It is important for patients to follow the doctor's instructions to ensure accurate results.

Patients should be aware of potential side effects, such as injection site reactions or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site reactions and nausea. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before the procedure.

General data about METASTRON 37 MBq / ml

  • Substance: strontium chloride
  • Date of last drug list: 01-07-2013
  • Commercial code: W42471001
  • Concentration: 37 MBq / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: GE HEALTHCARE LIMITED - MAREA BRITANIE
  • Holder: GE HEALTHCARE LIMITED - MAREA BRITANIE
  • Number: 8755/2016/01
  • Shelf life: 28 days de la data de referinta